- Home
- IMTE vs ADTX Comparison
IMTE vs ADTX Comparison
Compare IMTE & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTE
- ADTX
- Stock Information
- Founded
- IMTE 2008
- ADTX 2017
- Country
- IMTE Malaysia
- ADTX United States
- Employees
- IMTE N/A
- ADTX N/A
- Industry
- IMTE Consumer Electronics/Appliances
- ADTX Biotechnology: Pharmaceutical Preparations
- Sector
- IMTE Consumer Staples
- ADTX Health Care
- Exchange
- IMTE Nasdaq
- ADTX Nasdaq
- Market Cap
- IMTE 4.6M
- ADTX 5.3M
- IPO Year
- IMTE N/A
- ADTX 2020
- Fundamental
- Price
- IMTE $1.30
- ADTX $2.30
- Analyst Decision
- IMTE
- ADTX
- Analyst Count
- IMTE 0
- ADTX 0
- Target Price
- IMTE N/A
- ADTX N/A
- AVG Volume (30 Days)
- IMTE 126.6K
- ADTX 595.9K
- Earning Date
- IMTE 05-06-2025
- ADTX 05-19-2025
- Dividend Yield
- IMTE N/A
- ADTX N/A
- EPS Growth
- IMTE N/A
- ADTX N/A
- EPS
- IMTE N/A
- ADTX N/A
- Revenue
- IMTE $123,337.00
- ADTX $133,985.00
- Revenue This Year
- IMTE N/A
- ADTX $15,768.94
- Revenue Next Year
- IMTE N/A
- ADTX N/A
- P/E Ratio
- IMTE N/A
- ADTX N/A
- Revenue Growth
- IMTE 4.75
- ADTX N/A
- 52 Week Low
- IMTE $0.51
- ADTX $2.04
- 52 Week High
- IMTE $3.84
- ADTX $27,200.00
- Technical
- Relative Strength Index (RSI)
- IMTE 47.16
- ADTX 30.49
- Support Level
- IMTE $1.20
- ADTX $2.04
- Resistance Level
- IMTE $1.30
- ADTX $2.39
- Average True Range (ATR)
- IMTE 0.14
- ADTX 0.45
- MACD
- IMTE -0.03
- ADTX 0.48
- Stochastic Oscillator
- IMTE 16.63
- ADTX 7.54
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.